| Size | Price | Stock | Qty |
|---|---|---|---|
| 500mg |
|
||
| 1g |
|
||
| Other Sizes |
| ln Vitro |
Over 75% of P. aeruginosa isolates were suppressed by 12.5 μg/mL of azocellin. Azlocillin exhibits antibacterial activity against both positive and indole-negative Proteus bacteria, demonstrating 98% and 71% inhibition, respectively, at a 12.5 μg/mL concentration. All Gram-positive cocci are susceptible to azlocillin, with the exception of Staphylococcus aureus, which is resistant to penicillin G [1].
|
|---|---|
| ln Vivo |
Treatment with azlocillin (75 mg/kg) enhances survival in neutropenic mice infected with Escherichia coli or Klebsiella pneumoniae [2].
|
| ADME/Pharmacokinetics |
Absorption, Distribution and Excretion
Gastrointestinal absorption is minimal. Metabolism/Metabolites Primarily excreted via the kidneys, but also undergoes biotransformation in tissues and is degraded by intestinal bacteria, resulting in higher concentrations in bile. Biological Half-Life The average elimination half-life is 1.3 to 1.5 hours. The half-life is longer in newborns and 2 to 6 hours in patients with renal insufficiency. |
| Toxicity/Toxicokinetics |
Protein Binding
20% to 46% binds to plasma proteins. |
| References |
|
| Additional Infomation |
Azlocillin is a semi-synthetic penicillin with a 6β-{(2R)-2-[(2-oxoimidazolidine-1-carbonyl)amino]-2-phenylacetyl}amino side chain. It is an antibiotic used to treat infections caused by Pseudomonas aeruginosa, Escherichia coli, and Haemophilus influenzae. It is an antibacterial drug. It is a penicillin, a semi-synthetic derivative, and also a penicillin allergen. It is the conjugate acid of azlocillin(1-). Azlocillin is a semi-synthetic ampicillin derivative acylurea penicillin. Azlocillin has been reported in Apis cerana, and there is relevant data. Azlocillin is a semi-synthetic broad-spectrum acylchlorine penicillin with antibacterial activity. Azlocillin binds to penicillin-binding protein (PBP) located within the bacterial cell wall, thereby inhibiting the cross-linking of peptidoglycan, a key component of the bacterial cell wall. This prevents the normal synthesis of the bacterial cell wall, leading to weakening of the bacterial cell wall and ultimately cell lysis.
A semi-synthetic ampicillin derivative, belonging to the acylurea penicillin class. See also: Aloxicillin sodium (note moved to). Indications For the treatment of infections caused by Pseudomonas aeruginosa, Escherichia coli, and Haemophilus influenzae. Mechanism of Action Aloxicillin inhibits the third and final stage of bacterial cell wall synthesis by binding to a specific penicillin-binding protein (PBP) located within the bacterial cell wall. Cell lysis is mediated by bacterial cell wall autolysins (such as autolysins); aloxicillin may interfere with autolysin inhibitors. |
| Molecular Formula |
C20H22N5NAO6S
|
|---|---|
| Molecular Weight |
483.4734
|
| Exact Mass |
483.118
|
| CAS # |
37091-65-9
|
| Related CAS # |
Azlocillin;37091-66-0
|
| PubChem CID |
6479523
|
| Appearance |
White to off-white solid powder
|
| LogP |
0.1
|
| Hydrogen Bond Donor Count |
4
|
| Hydrogen Bond Acceptor Count |
7
|
| Rotatable Bond Count |
5
|
| Heavy Atom Count |
32
|
| Complexity |
844
|
| Defined Atom Stereocenter Count |
4
|
| SMILES |
CC1([C@@H](N2[C@H](S1)[C@@H](C2=O)NC(=O)[C@@H](C3=CC=CC=C3)NC(=O)N4CCNC4=O)C(=O)O)C
|
| InChi Key |
JTWOMNBEOCYFNV-NFFDBFGFSA-N
|
| InChi Code |
InChI=1S/C20H23N5O6S/c1-20(2)13(17(28)29)25-15(27)12(16(25)32-20)22-14(26)11(10-6-4-3-5-7-10)23-19(31)24-9-8-21-18(24)30/h3-7,11-13,16H,8-9H2,1-2H3,(H,21,30)(H,22,26)(H,23,31)(H,28,29)/t11-,12-,13+,16-/m1/s1
|
| Chemical Name |
(2S,5R,6R)-3,3-dimethyl-7-oxo-6-[[(2R)-2-[(2-oxoimidazolidine-1-carbonyl)amino]-2-phenylacetyl]amino]-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid
|
| HS Tariff Code |
2934.99.9001
|
| Storage |
Powder -20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month Note: Please store this product in a sealed and protected environment, avoid exposure to moisture. |
| Shipping Condition |
Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)
|
| Solubility (In Vitro) |
DMSO : ~100 mg/mL (~206.84 mM)
H2O : ~6.67 mg/mL (~13.80 mM) |
|---|---|
| Solubility (In Vivo) |
Solubility in Formulation 1: ≥ 2.5 mg/mL (5.17 mM) (saturation unknown) in 10% DMSO + 40% PEG300 + 5% Tween80 + 45% Saline (add these co-solvents sequentially from left to right, and one by one), clear solution.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 400 μL PEG300 and mix evenly; then add 50 μL Tween-80 to the above solution and mix evenly; then add 450 μL normal saline to adjust the volume to 1 mL. Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH₂ O to obtain a clear solution. Solubility in Formulation 2: ≥ 2.5 mg/mL (5.17 mM) (saturation unknown) in 10% DMSO + 90% (20% SBE-β-CD in Saline) (add these co-solvents sequentially from left to right, and one by one), clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 900 μL of 20% SBE-β-CD physiological saline solution and mix evenly. Preparation of 20% SBE-β-CD in Saline (4°C，1 week): Dissolve 2 g SBE-β-CD in 10 mL saline to obtain a clear solution. View More
Solubility in Formulation 3: ≥ 2.5 mg/mL (5.17 mM) (saturation unknown) in 10% DMSO + 90% Corn Oil (add these co-solvents sequentially from left to right, and one by one), clear solution. Solubility in Formulation 4: 100 mg/mL (206.84 mM) in PBS (add these co-solvents sequentially from left to right, and one by one), clear solution; with ultrasonication. |
| Preparing Stock Solutions | 1 mg | 5 mg | 10 mg | |
| 1 mM | 2.0684 mL | 10.3419 mL | 20.6838 mL | |
| 5 mM | 0.4137 mL | 2.0684 mL | 4.1368 mL | |
| 10 mM | 0.2068 mL | 1.0342 mL | 2.0684 mL |
*Note: Please select an appropriate solvent for the preparation of stock solution based on your experiment needs. For most products, DMSO can be used for preparing stock solutions (e.g. 5 mM, 10 mM, or 20 mM concentration); some products with high aqueous solubility may be dissolved in water directly. Solubility information is available at the above Solubility Data section. Once the stock solution is prepared, aliquot it to routine usage volumes and store at -20°C or -80°C. Avoid repeated freeze and thaw cycles.
Calculation results
Working concentration： mg/mL；
Method for preparing DMSO stock solution： mg drug pre-dissolved in μL DMSO (stock solution concentration mg/mL). Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug.
Method for preparing in vivo formulation:：Take μL DMSO stock solution, next add μL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O，mix and clarify.
(1) Please be sure that the solution is clear before the addition of next solvent. Dissolution methods like vortex, ultrasound or warming and heat may be used to aid dissolving.
(2) Be sure to add the solvent(s) in order.
Products are for research use only; We do not sell to patients
Copyright 2020 InvivoChem LLC | All Rights Reserved
